Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
When Seeking Alpha reached out to me in late 2021 to see if I would be interested in writing an article about my outlook for 2022, I appreciated this opportunity to participate in their virtual round table.
Over the past 3 months, 5 analysts have published their opinion on Targa Resources (NYSE:TRGP) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.